Evidence map›Paper›PMID 39104820›Full record

ArticleFrontiers in endocrinology2024

Case report: Comprehensive follow-up of a Colombian family carrying a novel MEN1 variant linked to a rare ACTH-producing pancreatic neuroendocrine carcinoma.

Julián C Riaño-Moreno, Angélica María González-Clavijo, William C Torres J, Vilma L Medina B, Alfredo Ernesto Romero-Rojas, Isabella Vieda-Celemin, Jordan A Avila-Moya, Johan A Baron-Cardona, Juan P Bravo-Patiño, Oscar S Torres-Zambrano and 1 more

Abstract readCase Reports
In one paragraph

Article in Frontiers in endocrinology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Julián C Riaño-Moreno *Department of Pathology and Molecular Oncology, Instituto Nacional de Cancerología, Bogotá, Colombia.
Angélica María González-Clavijo *Department of Physiological Sciences, Faculty of Medicine, Universidad Nacional de Colombia, Bogotá, Colombia.
William C Torres JDepartment of Pathology and Molecular Oncology, Instituto Nacional de Cancerología, Bogotá, Colombia.
Vilma L Medina BDepartment of Pathology and Molecular Oncology, Instituto Nacional de Cancerología, Bogotá, Colombia.
Alfredo Ernesto Romero-RojasEndocrine Oncology Unit, Instituto Nacional de Cancerología, Bogotá, Colombia.
Isabella Vieda-CeleminDepartment of Physiological Sciences, Faculty of Medicine, Universidad Nacional de Colombia, Bogotá, Colombia.
Jordan A Avila-MoyaDepartment of Physiological Sciences, Faculty of Medicine, Universidad Nacional de Colombia, Bogotá, Colombia.
Johan A Baron-CardonaDepartment of Physiological Sciences, Faculty of Medicine, Universidad Nacional de Colombia, Bogotá, Colombia.
Juan P Bravo-PatiñoDepartment of Physiological Sciences, Faculty of Medicine, Universidad Nacional de Colombia, Bogotá, Colombia.
Oscar S Torres-ZambranoDepartment of Physiological Sciences, Faculty of Medicine, Universidad Nacional de Colombia, Bogotá, Colombia.
Luis Felipe Fierro MayaEndocrine Oncology Unit, Instituto Nacional de Cancerología, Bogotá, Colombia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Multiple Endocrine Neoplasia type 1 (MEN1) is an autosomal dominant disorder marked by pathogenic variants in the MEN1 tumor suppressor gene, leading to tumors in the parathyroid glands, pancreas, and pituitary. The occurrence of ACTH-producing pancreatic neuroendocrine carcinoma is exceedingly rare in MEN1. Case presentation: This report details a Colombian family harboring a novel MEN1 variant identified through genetic screening initiated by the index case. Affected family members exhibited primary hyperparathyroidism (PHPT) symptoms from their 20s to 50s. Uniquely, the index case developed an ACTH-secreting pancreatic neuroendocrine carcinoma, a rarity in MEN1 syndromes. Proactive screening enabled the early detection of pituitary neuroendocrine tumors (PitNETs) as microadenomas in two carriers, with subsequent surgical or pharmacological intervention based on the clinical presentation. Conclusion: Our findings underscore the significance of cascade screening in facilitating the early diagnosis and individualized treatment of MEN1, contributing to better patient outcomes. Additionally, this study brings to light a novel presentation of ACTH-producing pancreatic neuroendocrine carcinoma within the MEN1 spectrum, expanding our understanding of the disease's manifestations.

Indexed as

Adrenocorticotropic HormoneCarcinoma, NeuroendocrineMultiple Endocrine Neoplasia Type 1Pancreatic NeoplasmsAdultColombiaFemaleFollow-Up StudiesHumansMaleMiddle AgedPedigreeProto-Oncogene ProteinsAdrenocorticotropic HormoneMEN1 protein, humanProto-Oncogene Proteinscascade genetic screeningframeshift variantmultiple endocrine neoplasia type 1 (MEN1)neuroendocrine - carcinomaneuroendocrine tumors (NETs)

Identifiers

PMID39104820
PMCPMC11298364

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.